An international study led by researchers from the University of the Basque Country (EHU) and the Biogipuzkoa health research institute (IIS Biogipuzkoa) has identified MARCO receptor as a new therapeutic target in intrahepatic cholangiocarcinoma (iCCA), one of the most aggressive forms of liver cancer and one with the poorest prognosis. CCA is a cancer of…
